About Icons

Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

Drug Description in Trials / DrugBank / KEGG DRUG

Search results

No.

DrugBank

Drug (Description in trials)

KEGG DRUG

KEGG GENES

KEGG PATHWAY

Disease ID

1

[1] Setmelanotide

[2] Setmelanotide ,
Setmelanotide acetate 💬

[1] MC4R 💬

[3] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬

[5] 134, 193, 202, 236, 265 💬

2

[2] Somatotropin; Somatropin

[1] Somatropin 💬

[1] GHR 💬

[6] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬

[3] 3, 65, 236 💬

3

[1] Theophylline

[3] Theophylline ,
Theophylline ,
Theophylline sodium glycinate 💬

[18] ADORA1,
ADORA2B,
PDE10A,
PDE11A,
PDE1A,
PDE1B,
PDE1C,
PDE2A,
PDE3A,
PDE3B,
PDE4A,
PDE4B,
PDE4C,
PDE4D,
PDE7A,
PDE7B,
PDE8A,
PDE8B 💬

Name	Full Name
ADORA1	adenosine receptor A1 isoform 1
ADORA2B	adenosine receptor A2b
PDE10A	cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A isoform 3
PDE11A	dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A isoform 4
PDE1A	dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A isoform 2
PDE1B	dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B isoform 1
PDE1C	dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C isoform 2
PDE2A	cGMP-dependent 3',5'-cyclic phosphodiesterase isoform PDE2A3
PDE3A	cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A isoform 1
PDE3B	cGMP-inhibited 3',5'-cyclic phosphodiesterase 3B isoform 2
PDE4A	3',5'-cyclic-AMP phosphodiesterase 4A isoform 1
PDE4B	3',5'-cyclic-AMP phosphodiesterase 4B isoform 1
PDE4C	3',5'-cyclic-AMP phosphodiesterase 4C isoform 1
PDE4D	3',5'-cyclic-AMP phosphodiesterase 4D isoform PDE4D4
PDE7A	high affinity 3',5'-cyclic-AMP phosphodiesterase 7A isoform c
PDE7B	3',5'-cyclic-AMP phosphodiesterase 7B
PDE8A	high affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A isoform 1
PDE8B	high affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B isoform 1

[23] Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬

[2] 236, 299 💬